Since sodium accumulation together with impaired vascular function contributes to the development of hypertension and associated cardiovascular pathologies, NDP-α-MSH treatment might have a dual therapeutic effect by interrupting these critical pathophysiological processes. Here, STAMBP is linked to Hypertension.